Medical education scope Arbor Scientia Group specializes in medical education across a broad range of disease areas including neurology, psychiatry, hematology, oncology, rare diseases, immunology, virology, cardiovascular, women’s health, urology, diabetes and gastroenterology, indicating opportunities to cross-sell educational content, training modules, and thought leadership programs to multiple therapeutic areas.

PhD-led expertise With a staff of PhD-trained scientists, communication experts, creatives, and client services teams, the firm can position itself as a high-caliber partner for scientifically rigorous content development, medical journals, and speaker programs—appealing to pharma, biotech, and academic clients seeking credibility and precision.

Tech-enabled delivery Utilizes a modern tech stack including Adobe Creative Cloud, AWS, WordPress, Figma, Shopify, Articulate Storyline, Google Workspace, and WP Engine, enabling scalable digital education, e-learning modules, interactive campaigns, and robust content distribution for potential clients looking to modernize medical education.

Revenue range Current revenue is estimated between $50M and $100M, suggesting the company has substantial project capacity and could engage in larger, multi-year collaborations, global campaigns, or multi-disease education programs with enterprise-level sponsors.

Growth opportunities Operating across the United States with a diverse disease focus and a mid-sized employee base (11-50), Arbor Scientia Group could expand through strategic partnerships, expanded clinical areas, and enhanced digital offerings to attract larger healthcare, life sciences, and pharmaceutical clients seeking specialized medical education solutions.